Back to Search Start Over

Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.

Authors :
Nittayacharn, Pinunta
Abenojar, Eric
Cooley, Michaela B.
Berg, Felipe M.
Counil, Claire
Sojahrood, Amin Jafari
Khan, Muhammad Saad
Yang, Celina
Berndl, Elizabeth
Golczak, Marcin
Kolios, Michael C.
Exner, Agata A.
Source :
Journal of Controlled Release. Mar2024, Vol. 367, p135-147. 13p.
Publication Year :
2024

Abstract

Liver metastasis is a major obstacle in treating aggressive cancers, and current therapeutic options often prove insufficient. To overcome these challenges, there has been growing interest in ultrasound-mediated drug delivery using lipid-shelled microbubbles (MBs) and nanobubbles (NBs) as promising strategies for enhancing drug delivery to tumors. Our previous work demonstrated the potential of Doxorubicin-loaded C 3 F 8 NBs (hDox-NB, 280 ± 123 nm) in improving cancer treatment in vitro using low-frequency unfocused therapeutic ultrasound (TUS). In this study, we investigated the pharmacokinetics and biodistribution of sonicated hDox-NBs in orthotopic rat liver tumors. We compared their delivery and therapeutic efficiency with size-isolated MBs (hDox-MB, 1104 ± 373 nm) made from identical shell material and core gas. Results showed a similar accumulation of hDox in tumors treated with hDox-MBs and unfocused therapeutic ultrasound (hDox-MB + TUS) and hDox-NB + TUS. However, significantly increased apoptotic cell death in the tumor and fewer off-target apoptotic cells in the normal liver were found upon the treatment with hDox-NB + TUS. The tumor-to-liver apoptotic ratio was elevated 9.4-fold following treatment with hDox-NB + TUS compared to hDox-MB + TUS, suggesting that the therapeutic efficacy and specificity are significantly increased when using hDox-NB + TUS. These findings highlight the potential of this approach as a viable treatment modality for liver tumors. By elucidating the behavior of drug-loaded bubbles in vivo , we aim to contribute to developing more effective liver cancer treatments that could ultimately improve patient outcomes and decrease off-target side effects. [Display omitted] • Bubble size is a critical factor in ultrasound-mediated drug delivery to tumors. • Nanobubbles excited with ultrasound deliver more drugs to tumors than microbubbles. • Nanobubbles + ultrasound increase apoptotic cell death in tumors while sparing normal liver. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01683659
Volume :
367
Database :
Academic Search Index
Journal :
Journal of Controlled Release
Publication Type :
Academic Journal
Accession number :
176195654
Full Text :
https://doi.org/10.1016/j.jconrel.2024.01.028